Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 108, 165-172
Abstract
No abstract availableKeywords
Funding Information
- Spanish Ministry of Science (AGL-2008-03710, AGL-2011-22485)
- European Community’s Seventh Framework Programme (FP7-228394)
This publication has 28 references indexed in Scilit:
- Breaking the chain: Rift Valley fever virus control via livestock vaccinationCurrent Opinion in Virology, 2012
- Culex pipiens, an Experimental Efficient Vector of West Nile and Rift Valley Fever Viruses in the Maghreb RegionPLOS ONE, 2012
- Experimental Infection of Young Adult European Breed Sheep with Rift Valley Fever Virus Field IsolatesVector-Borne and Zoonotic Diseases, 2010
- Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheepVaccine, 2010
- Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)PLOS ONE, 2009
- Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challengeVaccine, 2007
- Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteinsVirology, 2007
- Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challengeVaccine, 2006
- Rift Valley FeverScientific and Technical Review, 2004
- Rift Valley fever: an uninvited zoonosis in the Arabian peninsulaInternational Journal of Antimicrobial Agents, 2003